Clinical
RESOURCES
Employee Wellness Tips for Healthcare Workers
The spread of COVID-19 has affected every industry, every facet of life. But its impact on healthcare providers is significantly higher than most and continues to create a ripple effect of significant burdens. Not only are healthcare workers experiencing grave challenges at work, but their concerns and worries extend home to their family members. Heathcare […]
ViewBridging gaps and building bridges to navigate healthcare avoidance
The current paradigm to strive to diagnose and treat diseases early and effectively remains unquestionable. However, COVID-19 has challenged this central dogma and left us with an unparalleled growing global healthcare crisis. Reports are clear that the pandemic is creating numerous ripple effects for patients who are facing delays to both the diagnosis and treatment […]
ViewInteractive checklist for the restarting/starting of research
Many non-COVID-19 studies have been paused or delayed starting due to the global pandemic. The National Institute for Health Research (NIHR) has provided a Restart Framework that describes how NIHR research activities can resume. To help you navigate the necessary steps to be taken before NIHR clinical trials can restart, we have created an interactive checklist that will guide you through this process. The Restart Framework will continue to evolve in the context of learned experience and this tool will be updated to align with any changes to the NIHR’s guidance. For further details, please see the complete NIHR Restart Framework.
Download PDFEnsuring an Open Channel with Regulatory and Medical Policy Opinion Leaders During COVID
Many companies, particularly new entrants into the U.S. pharma arena, are facing some level of disruption or impact on their projected timelines for seeking FDA licensure, gathering data from trials for filing, conducting health economics analyses needed to demonstrate improved outcomes, or conducting real-world evidence studies that can help inform medical societies’ deliberations on clinical […]
View2020 and the luxury of limitations for clinical trials
COVID-19 has had a fundamental effect on every aspect of society, including clinical trials. The search for an effective vaccine or treatment for COVID-19 continues to move at record pace. However, many clinical trials in other therapeutic areas have either been delayed or essentially ground to a halt due to the pandemic. Such delays place […]
ViewAssessing and managing issues around clinical trials: a multi-stakeholder approach
Many companies are facing challenging decisions on whether to proceed with clinical trials in the coming months as countries experience varying degrees of lockdown.
ViewVirtual training that excites
This virtual meeting and training infographic provides useful tips on how to make the most of virtual meetings by bridging the gap between a face-to-face experience and a virtual environment.
Download PDFSupporting study participants
We have developed a checklist of reminders for the site staff who are at the frontlines interacting with participants, patients and caregivers. This checklist offers practical reminders to enhance their day-to-day interactions with study participants.
Download PDFUnlocking virtual medical congresses
Medical congresses – crucial for the presentation of trial data, scientific exchange and the opportunity to engage with medical professionals, patient advocates, media and analysts – have been cancelled, postponed or are moving to virtual/part virtual.
ViewNo two virtual congresses are the same
Each congress has a different structure to its overall program and method in delivering its scientific information, despite stating that they all plan to keep to the traditional congress format.
Download PDFGet in Touch
We know there are numerous considerations when it comes to the impact of COVID-19 and what this means for your organization. We are here to help.